Repligen Corporation (RGEN) at a glance

Repligen Corporation (RGEN) is a Healthcare company. It trades at $131.23. It does not pay a dividend. Vestovix scores it 49/100 overall. Its strongest dimension is Safety (60/100) and its weakest is Income (40/100).

Price
$131.23
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$100.99 to $175.77
Vestovix Score49/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
42